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CCR5 and CXCR4 are the two major coreceptors that have been identified for human immunodeficiency virus (HIV) entry.
We have modified several b-galactosidase-based HIV indicator cell lines to express CCR5 and/or CXCR4. Using these new
reagents, we have been able to detect all primary isolates tested using one or both of these cell lines. However, there is
large variation in the absolute viral infectivity among primary strains. Furthermore, all HIV strains are capable of causing
syncytia in the indicator cells when the coreceptor is present regardless of whether they had previously been characterized
as ‘‘syncytia-inducing’’ or ‘‘non-syncytium-inducing.’’ q 1997 Academic Press
INTRODUCTION lar cell lines based on a human glioblastoma cell line,
U373 ((Harrington and Geballe, 1993), called U373-MAGI
Human immunodeficiency virus (HIV) replicates pri- cells here), and a rhesus macaque mammary tumor cell
marily in T-lymphocytes and cells of the macrophage line, CMMT (Chackerian et al., 1995) have also been
lineage. Although CD4 is required for virus binding to the made.
cell surface, viral fusion with the cell membrane requires Although the HeLa-MAGI cells detect many laboratory-
a coreceptor. HIV-1 strains called M-tropic use CCR5 adapted (T-tropic) isolates of HIV-1, they detect only a
for the coreceptor, and those called T-tropic use CXCR4 minority of primary isolates (Kimpton and Emerman,
(Alkhatib et al., 1996; Berson et al., 1996; Choe et al., 1992) and do not detect SIV strains. U373-MAGI cells,
1996; Deng et al., 1996; Dragic et al., 1996; Feng et al., on the other hand, could not be infected with any (M- or
1996). CCR5 is also a receptor for the b-chemokines MIP- T-tropic) strain of HIV, but could be complemented by
1a, MIP-1b, and RANTES (Raport et al., 1996; Samson fusion with HeLa cells to enable infection (Harrington
et al., 1996), while CXCR4 is also a receptor for the a- and Geballe, 1993). Presumably, the HeLa-MAGI cells
chemokine SDF-1 (Bleul et al., 1996; Oberlin et al., 1996). are unable to detect M-tropic strains of virus because
A few viral isolates use CCR2b and CCR3 as coreceptors HeLa cells express CXCR4, but not CCR5 (Alkhatib et al.,
in addition to CCR5 and/or CXCR4 (Doranz et al., 1996). 1996; Deng et al., 1996). Thus, the original HeLa-MAGI
We had previously developed an indicator cell line for cells were not useful for detection of most primary iso-
rapid detection and quantitation of HIV infection (Kimpton lates (Kimpton and Emerman, 1992) because the majority
and Emerman, 1992). This assay, called the MAGI assay, of virus isolates from HIV-positive people are M-tropic,
uses HeLa cells that express human CD4 and an inte- although T-tropic strains can also be present and are
grated HIV-1 long terminal repeat (LTR) driving expres- relatively more frequent at later stages of disease pro-
sion of b-galactosidase that has been modified with a gression (Jurriaans et al., 1994; Valentin et al., 1994; Zhu
nuclear localization signal on the N-terminus of the pro- et al., 1993). Therefore, we wished to develop more gen-
tein. Integration of an HIV provirus in these cells leads eral assays for rapid and quantitative detection of HIV
to production of the viral transactivator, Tat, which then and SIV strains using indicator cell lines that express
turns on expression of the b-galactosidase gene. The individual or multiple different coreceptors.
number of cells that stain positive with X-gal for b-galac-
tosidase activity in situ is directly proportional to the num-
MATERIALS AND METHODSber of infected cells (Kimpton and Emerman, 1992). Simi-
Construction of indicator cell lines
1 These authors contributed equally to this work. The wild-type CCR5 gene was modified with a prolac-2 To whom correspondence and reprint requests should be ad-
tin signal peptide followed by an epitope tag (FLAG) asdressed at Fred Hutchinson Cancer Research Center, Suite C2-023,
described (Raport et al., 1996) and inserted into the ret-P.O. Box 19024, 1100 Fairview Avenue N., Seattle, WA 98109-1024. Fax:
(206) 667-6523. E-mail: memerman@fhcrc.org. roviral vector pBabe-Puro (Morgenstern and Land, 1990).
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Other CCR5 alleles were cloned by PCR from a cohort facturer’s instructions (QIAGEN). cDNAs were then pre-
pared using Superscript reverse transcriptase (Gibco-of HIV seronegative individuals (W. C. Goh, manuscript
in preparation) using a 5* CCR5 primer tagged with a BRL) and random primers (Boehringer-Mannheim). To
detect CCR5 and CXCR4 mRNA, aliquots of the cDNAsFLAG epitope, but without the prolactin signal peptide.
PCR conditions to amplify CCR5 consisted of 5 cycles of were amplified by Taq polymerase using primers that
flank the 5* and 3* ends of the respective genes using947 for 1 min, 457 for 1 min, 727 for 2 min, followed by 25
cycles of 947 for 1 min, 607 for 1 min, 727 for 2 min using the primers described above. PCR products were then
analyzed on ethidium-bromide-stained agarose gels. Forprimers CCR5 primers 5* ATGGACTACAAGGACGAT-
GACAAGGATTATCAAGTGTCA 3* and 5* GAGTCCGTG- detection of epitope-tagged coreceptors on cell surfaces,
11 106 cells were washed once in PBS with 1 mM CaCl2 ,TCACAAGCCCAC 3*. The entire PCR product was se-
quenced and cloned into pBabe-Puro. One CCR5 allele resuspended in 50 ml of the same solution with 1 mg of
anti-FLAG M1 Ab (Immunex), and incubated on ice forthat contained several point mutations is called CCR5E
in this report. CXCR4 (Raport et al., 1995) was also ampli- 30 min. The secondary antibody was an FITC-conjugated
anti-mouse (Jackson).fied with and without the same leader and epitope tag
and inserted into pBabe-Puro. CXCR4 PCR conditions
without the leader consisted of 30 cycles of 947 for 1 RESULTS
min, 607 for 1 min, 727 for 2 min, and primers were 5*
Indicator cells that express either CCR5 or CXCR4
GCGGTTACCATGGAGGGGATCAGTA 3* and 5* GTT-
AGCTGGAGTGAAAACTTGAAGA 3*. First, we verified that the reason U373-MAGI cells
could not be infected with any strain of HIV in a previousHigh-titer stocks of the Babe-Puro retroviral vector
pseudotyped with the VSV-G protein were made by tran- study (Harrington and Geballe, 1993) was the lack of
expression of either of the major HIV-1 coreceptors. RT-sient transfection as described (Bartz et al., 1996) and
used to infect HeLa-MAGI and U373-MAGI cells. Cells PCR was performed to amplify RNA of CCR5 and CXCR4.
Indeed, the inability of the U373-MAGI cells to be infectedresistant to 0.6 mg/ml puromycin (HeLa) or 1 mg/ml puro-
mycin (U373) were pooled. Each pool contained at least correlates with their lack of detectable levels of either
CXCR4 or CCR5 transcripts (Fig. 1A). Therefore, to con-1000 independent transduction events. U373-MAGI cells
(Harrington and Geballe, 1993) were obtained from R. struct indicator cell lines that could detect M- or T-tropic
viruses separately, epitope-tagged versions of the HIV-1Harrington and A. Geballe (Fred Hutchinson Cancer Re-
search Center). An early passage (passage 2) stock of coreceptors CCR5 and CXCR4 were introduced into
U373-MAGI cells by infection with a retroviral vector tothe original HeLa-MAGI cells (Kimpton and Emerman,
1992) was used to create HeLa-MAGI-CCR5 cells. make U373-MAGI-CCR5 and U373-MAGI-CXCR4 cells,
respectively. Expression of the coreceptors on the cellInfections and viral titers
surface of pooled colonies was demonstrated by immu-
Infection of the indicator cell lines with HIV was per- nostaining live cells (data not shown) and by RT-PCR
formed in 12-well plates with 10-fold serial dilutions of (Fig. 1). CXCR4 expression was considerably higher than
300 ml of virus in the presence of 20 mg/ml DEAE-dextran CCR5 expression in these cells (data not shown).
as described (Kimpton and Emerman, 1992). Two days The U373-MAGI, U373-MAGI-CCR5, and U373-MAGI-
after infection, cells were fixed and stained for b-galac- CXCR4 cells were then infected with limiting dilutions of
tosidase activity with X-gal as described except that a T-tropic strain of HIV-1 (HIVLAI), an M-tropic strain (HI-U373-derived MAGI cells were stained for 135 min at VYU-2), and an SIV isolate, SIVMAC239. Infectivity was mea-377 instead of 50 min for the HeLa-derived MAGI cells. sured by counting the number of blue cells per well per
Background staining of noninfected wells never ex- volume of virus (Table 1). The titer of HIV-1LAI was lessceeded 10 blue cells per well. Only dark blue cells were than 100 on U373-MAGI-CCR5, but over 1 1 106 on
counted, and syncytia with multiple nuclei were counted U373-MAGI-CXCR4 cells (Table 1). In contrast, the titer of
as a single infected cell. The infectious titer is the number HIVYU-2 on U373-MAGI-CCR5 cells was 2 1 106 while theof blue cells per well multiplied by the dilution of virus titer on U373-MAGI-CXCR4 cells was about 600. This
and normalized to 1 ml. shows that the specificity of viral infection for use of a given
All HIV-1 strains and SIVmac239 were obtained from the coreceptor can be greater than 4 orders of magnitude.
NIH AIDS Reference and Reagent Program. Stocks from Although SIVmac239 infection was increased from 1.2
cloned proviruses were made by transient transfection. 1 103 to 4 1 105 in the presence of CCR5, it clearly
Other stocks were made by passage of virus in human
infected cells in the absence of either CCR5 or CXCR4
peripheral blood mononuclear cells. Viral stocks were
(Fig. 1 and Table 1). The presence of CXCR4 in the U373-
normalized by p24gag ELISA (Coulter Immunology) using
MAGI cells did not significantly increase the amount of
standards provided by the manufacturer.
infectivity above that for U373-MAGI alone (Table 1). This
Coreceptor expression levels indicates that SIVmac239 is dual-tropic; SIVmac239 can
use human CCR5 for infection, but also uses anotherTotal cellular RNA was isolated from 1 1 106 cells
using a commercially available kit according to the manu- human coreceptor that is not CXCR4. The coreceptor on
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FIG. 1. Expression of CXCR4 and CCR5 in cell lines. Reverse transcriptase (RT)-PCR was used to amplify whole-cell RNA from each of the
indicated cell lines using primers specific for CCR5 (left) or CXCR4 (right). Only U373-MAGI-CCR5 expressed CCR5, while CEMx174 and U373-
MAGI-CXCR4 expressed CXCR4. U7373-MAGI cells which expressed neither could be infected by SIV (Table 1). As controls, genomic DNA for both
CCR5 and CXCR4 was positive for all cell types (data not shown), and RT-PCR was negative in all cases where reverse transcriptase was omitted
from the reaction (data not shown).
U373 cells, or yet another coreceptor, must also exist in do not use CXCR4 in this context (Table 2). However, we
noticed a great disparity in the ability of each of these twoCEMX174 cells, the cells used to amplify this virus, be-
cause CEMX174 cells do not express CCR5 (Fig. 1). viruses to infect HeLa-MAGI-CCR5 cells. The infectivity of
a virus stock (Table 2) is the number of infectious units
Detection of primary isolates of HIV-1 independent of per physical particle (represented here by the amount of
clade: Infectivity as a variable of viral strain viral core protein). The infectivity of these two viruses
differed by over 50-fold in multiple viral stocks that wereWe then surveyed a series of primary uncloned strains
independently prepared (Table 2 and data not shown).and cloned M-tropic strains of HIV-1 for their ability to
We further examined the variability of infectivity of pri-infect indicator cell lines that express both CCR5 and
mary viral isolates by analyzing a collection of 12 differentCXCR4. For this purpose, CCR5 was introduced into
uncloned virus stocks from 3 different clades (Table 2).HeLa-MAGI cells to make HeLa-MAGI-CCR5. Because
All of the viruses had been designated as ‘‘non-syncy-HeLa cells express endogenous CXCR4 (Deng et al.,
tium-inducing’’ (NSI) viruses. Three clade A primary iso-1996), this cell line should be capable of detecting all
lates, three clade E isolates, and three additional cladestrains of HIV that use either of these two coreceptors.
B isolates from geographically diverse origins were used.Two cloned M-tropic viruses, HIVJR-CSF and HIVYU-2 ,
In all 9 cases, the primary strains of HIV could be de-both infected HeLa-MAGI-CCR5, but not HeLa-MAGI
tected on HeLa-MAGI-CCR5 cells, but not on HeLa-MAGIcells, indicating that both use CCR5 as a coreceptor and
cells (Table 2). However, the efficiency of infection varied
from 5 infectious units per nanogram of p24gag to over
TABLE 1 100 infectious units per nanogram of p24gag (Table 2).
These results indicate that absolute infectivity of M-tropicInfectious Titers of Viruses on U373 Cells That
strains varies considerably and is apparently indepen-Express Different Coreceptors
dent of clade. In addition, we have tested several SIV
Titer on cell line (IU/ml)b and HIV-2 strains and found that both primary and pas-
saged HIV-2 strains, as well as SIVMAC239 , can be titeredU373- U373-MAGI- U373-MAGI-
on the indicator cell lines that express human CCR5 (dataVirus straina MAGI CXCR4 CCR5
not shown).
HIV-1LAI 100 1.8 1 106 100
HIV-1YU-2 100 600 2.2 1 106 Syncytium induction by non-syncytium-inducing
SIVMAC239 1.2 1 103 1.4 1 103 4 1 105 viruses
a Viruses derived by transfection of molecular clones into human 293 The MAGI assay is sensitive to syncytia formation; the
cells.
infected cells can form large and small foci of infectionb Infectious units (IU) per milliliter is the number of blue cells per
containing multiple nuclei (Kimpton and Emerman, 1992).well multiplied by the dilution of virus supernatant and normalized to
1 ml final volume. It has been previously shown that the env gene of an
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TABLE 2
Detection of Primary HIV-1 Strains on HeLa-MAGI-CCR5 Cells
Viral subtype Titer (IU/ml) on
Virus straina (country of origin)b HeLa-MAGI-CCR5c P24gag ng/ml Infectivity d
HIV-1YU-2 B (USA) 620,000 2200 281
HIV-1JR-CSF B (USA) 12,000 2800 4.2
HIV-1TH020 E (Thailand) 4,133 93 44
HIV-1TH021 E (Thailand) 4,967 52 96
HIV-1TH022 E (Thailand) 200 15 13
HIV-1US660 B (USA) 2,367 127 19
HIV-1UG031 A (Uganda) 1,633 71 23
HIV-1RW009 A (Rwanda) 3,333 158 21
HIV-1RW026 A (Rwanda) 739 143 5.2
HIV-1US727 B (USA) 14,067 289 49
HIV-1US056 B (USA) 5,833 284 21
HIV-1LAI B (France) 280,000 167 1600
a HIV-1YU-2 , HIV-1JR-CSF , and HIV-1LAI were derived by transfection of molecular clones. All others were tested as crude supernatants of uncloned
viral stocks derived from infection of heterologous peripheral blood mononuclear cells.
b Clade designation according to Myers et al. (1995) for the env gene; country of origin refers to the country of residence of the HIV-positive
individual from whom blood was obtained for viral isolation (World Health Organization Viral Isolate Program). All of the primary strains are NSI
viruses.
c Infectious units (IU) per milliliter is the number of blue cells per well multiplied by the dilution of virus supernatant and normalized to 1 ml final
volume. All viruses, except HIV-1LAI , had fewer than 10 IU/ml when tested on HeLa-MAGI cells without CCR5. HIVLAI , a T-tropic strain, has a titer
of 2.8 1 105 on HeLa-MAGI cells with or without CCR5.
d Infectivity is the infectious units per nanogram of P24gag (column 3 divided by column 4).
NSI virus is fully capable of causing syncytia when ex- the HeLa-MAGI-CCR5 cells with the SIV strains, espe-
cially SIVMAC239, SIVMNEcl8, and SIVMNE170, was remark-pressed in a heterologous system (Broder and Berger,
1995; Li et al., 1996) when the proper coreceptor was able because the syncytia induced in the monolayer were
much larger than those induced by any of the HIV strainspresent. We therefore tested if the NSI viruses them-
selves could cause syncytia as a course of normal virus we have tested (Fig. 2C). This indicates that syncytia
induction is not a property unique to viruses that useinfection in the indicator cells. Indeed, we found that
not only did syncytia-inducing (SI) viruses cause syncytia CXCR4 as a coreceptor.
formation in these cells (data not shown), but in fact, the
NSI viruses caused syncytia as well (Fig. 2). These types Stability of indicator cell lines with wild-type and
of syncytia could be seen with all primary and passaged mutant CCR5
strains tested. Representative syncytia formed by the NSI
strain HIVJR-CSF and with an uncloned NSI clade E We noticed that the apparent titer of M-tropic viruses
appeared to decrease as the HeLa-MAGI-CCR5 cellsprimary strain are shown (Figs. 2A and 2B). Infection of
FIG. 2. Syncytium formation by M-tropic isolates of HIV-1 and SIV. HeLa-MAGI-CCR5 cells were infected at a multiplicity of infection of less than
0.001. Cells were fixed and stained with X-gal 40 hr after infection. (A) HIV-1JR-CSF ; (B) uncloned clade B primary strain of HIV-1; (C) SIVMAC239. The
nuclei of infected cells stain blue with X-gal (black in these photographs) because the b-galactosidase gene induced by infection was modified to
localize protein to the nucleus (Kimpton and Emerman, 1992). All photographs were taken at an original magnification of 201. Black arrows point
to syncytium. Note that multiple nuclei within the syncytium all stain with X-gal and the number of nuclei in the syncytium is an indicator of the
size of the syncytium. Syncytia induced by SIVMAC239 (and other SIV strains, data not shown) are consistently larger than any others seen with HIV-
1 strains. The white arrow in A points to a single infected cell and the white arrow in C points to a single uninfected cell.
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were passaged in culture. Thus, a frozen stock of virus have also found that CCR5 and CXCR4 are used by most,
if not all, HIV-1 strains regardless of clade (Simmons etwith a titer of 1.8 1 106 on an early passage of HeLa-
MAGI-CCR5 cells declined to a titer of 8 1 104 after al., 1996; Zhang et al., 1996). In addition to the strains
listed in Table 3, we have tested about 25 other primarythe cells had been in culture for approximately 3
months. This loss of function was observed in at least strains of HIV-1, all of which could be detected using the
indicator lines expressing CCR5 and/or CXCR4 (data notthree pools of clones made at different times and was
accompanied by a loss of CCR5 cell surface expres- shown). However, we found that the absolute infectivity
of primary viruses can vary quite dramatically. One hy-sion (data not shown). Thus, there appeared to be a
selection against long-term expression of CCR5 in pothesis is that the absolute infectivity depends on the
affinity of the V3 loop of each virus for CCR5 after CD4HeLa cells. However, in parallel to these studies we
had also been cloning and testing alleles of CCR5 from binding (Trkola et al., 1996; Wu et al., 1996) or depends
on the relative virion incorporation of envelope. By com-a cohort of HIV seronegative humans (W. C. Goh,
manuscript in preparation). These alleles of CCR5 parison, the infectivity of HIV-1LAI , a T-tropic strain that
uses CXCR4 as the coreceptor (Table 1), is higher thanwere also introduced into HeLa-MAGI cells and U373-
MAGI cells to test for their ability to function as core- that of the highest M-tropic strain tested. On the other
hand, the low level of infection by an M-tropic virus usingceptors for M-tropic strains of virus. Cells made from
one allele that contained mutations in the coding re- CXCR4 as a coreceptor (Table 1, column 2) might explain
how many primary strains can be ‘‘adapted’’ to grow ingion of CCR5 (called CCR5E) retained stable expres-
sion for at least 14 passages. For example, the titer of T-cell lines in tissue culture (for example, see Harrowe
and Cheng-Mayer (1995)) because small amounts of rep-frozen aliquots of HIV-1YU-2 (Table 1) was 1.2 1 106 on
HeLa-MAGI-CCR5E from passage 2 and was 1.6 1 106 lication in a cell line that did not express CCR5 (but did
express CXCR4) would eventually select for mutationson HeLa-MAGI-CCR5E from passage 15. This allele of
CCR5 contains three mutations (T284A, R319C, and that allowed for efficient use of CXCR4.
Two classifications of HIV strains that have been usedT340A). It also differs from the HeLa-MAGI-CCR5 pools
described above because it does not contain the pro- in the past are the those of M-tropic (macrophage-tropic)
and T-tropic (T-cell line tropic) and another designationlactin leader at the 5* end of the molecule (see Materi-
als and Methods). At present we do not know how of HIV based on syncytia formation. Although most M-
tropic viruses are NSI and most T-tropic strains are SI,these mutations affect CCR5 expression or stability,
and we are investigating the source of the mutations. exceptions to the rules exist (for example, see Dittmar
et al., (1997)). Our studies with different viral strains indi-
cate that the SI/NSI designation is not meaningful be-DISCUSSION
cause all viral strains form syncytia if the correct corecep-
tor is present. Because the designation of SI/NSI hasWe have constructed indicator cell lines to detect pri-
mary isolates of HIV-1, HIV-2, and SIV. One set of indica- usually been measured on T-cell lines such as MT2 cells
that do not express CCR5, the previous designationstor cell lines expresses each of the two coreceptors sep-
arately, while the other expressed both receptors to- would have failed to find syncytia formation by primary
viruses that did not use CXCR4 as a coreceptor. Indeed,gether. In the past, single-cycle assays for HIV-1 have
been useful in quantitation of viral stocks. However, the using assay systems with PBMC, others have also found
that M-tropic strains can cause syncytia formation (Toddcell lines previously developed for these assays could
detect only T-cell line-adapted viruses and primary vi- et al., 1995). Therefore, we propose that neither the SI/
NSI designation nor the M-tropic/T-tropic designationruses that used CXCR4 as the viral coreceptor, which
rendered them useless for studies of most patient iso- should be used, but rather they should be replaced by
designations based on coreceptor usage on defined indi-lates. The new cell lines described here should be useful
in many aspects of HIV research. In addition to their cator cells.
use in rapidly determining the coreceptor usage (CCR5
versus CXCR4) of any given strain, they could be used ACKNOWLEDGMENTS
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